Breast Pathology 2023
Breast Pathology — from Oakstone CME’s Masters of Pathology Series — outlines best practices for specimen handling and reporting, defined diagnostic criteria, improved recognition of less common diagnostic entities, and accurate interpretation of ancillary studies by using both routine microscopic examination and immunohistochemistry.
Breast Pathology — from Oakstone CME’s Masters of Pathology Series — is a comprehensive educational resource designed for pathologists, pathology assistants, and residents. This continuing medical education (CME) program provides attendees with the latest updates and best practices in breast pathology, with a focus on specimen handling, diagnostic criteria, recognition of less common lesions, and accurate interpretation of ancillary studies.
Directed by Laura C. Collins, MD, a renowned expert in breast pathology, this program aims to enhance participants’ proficiency in breast pathology by providing them with essential knowledge and skills. Through a combination of lectures, microscopy sessions, and case studies, participants will gain a deeper understanding of the classification, diagnosis, and reporting of various breast lesions.
One of the key objectives of this CME activity is to help pathologists classify proliferative breast, in situ, papillary, fibroepithelial, spindle cell, and vascular lesions. Participants will also learn how to differentiate between invasive and in situ lesions, identify a variety of uncommon benign and malignant lesions, and adhere to the guidelines for reporting prognostic and predictive factors in breast pathology.
Additionally, this program will cover the role of adjunctive molecular tests in breast pathology and provide an understanding of their applications and limitations. The latest information on the use of immunohistochemistry in resolving diagnostic problems will also be discussed.
By the end of this CME activity, participants will be able to:
- Evaluate diagnostic criteria and clinical significance of various common and uncommon breast lesions
- Develop strategies to resolve differential diagnostic problems encountered in breast pathology
- Utilize immunohistochemistry to resolve diagnostic problems
- Understand updated guidelines for ER, PR, and HER2 testing and reporting
- Apply molecular testing in breast cancer
This program is intended for practicing pathologists, pathology assistants, and residents who are seeking to enhance their knowledge and skills in breast pathology. It will provide a comprehensive overview of breast pathology, covering key topics such as intraductal proliferative lesions, papillary lesions, lobular carcinomas, mucinous lesions, spindle cell lesions, and more.
The program features an esteemed faculty of expert speakers who will share their insights and expertise. Here are some of the topics and speakers featured in the program:
- Intraductal Proliferative Lesions – Rachel Factor, MD
- Papillary Lesions of the Breast – Edi Brogi, MD, PhD
- Contemporary Considerations for Breast Core Needle Biopsies – Hannah Gilmore, MD
- Breast Fibroepithelial Tumours – An Update – Puay Hoon Tan, MD
- Mucinous Lesions of the Breast – Paula Ginter, MD
- Spindle Cell Lesions of the Breast – Gabrielle Baker, MD
- Vascular Lesions of the Breast – Gregory Bean, MD
- Epithelial-Myoepithelial Lesions of the Breast – Patrick McIntire, MD
- Small Glandular Proliferations and Mimics of Breast Carcinoma – Laura C. Collins, MD
- Inflammatory and Reactive Conditions in the Breast – Laura C. Collins, MD
- The Spectrum of Triple Negative Breast Cancers – Hannah Wen, MD, PhD
- Breast Pathology in the Era of Genomics – Hannah Wen, MD, PhD
- Updates in Immunohistochemistry in Diagnostic Breast Pathology – Ashley Cimino-Mathews, MD
- Applications of Digital Pathology in the Field of Breast Pathology – Matthew Hanna, MD
In addition to the comprehensive coverage of breast pathology topics, this program also provides attendees with the opportunity to participate in microscopy sessions and slide seminars, where they can further enhance their diagnostic skills by examining case studies under the guidance of expert faculty.
By participating in this educational activity, attendees can earn CME credits that can contribute to their professional development. The program’s date of original release is March 1, 2023, and the credits will expire on February 28, 2026. So, it’s important to take advantage of this educational opportunity within the given timeframe.
Order your copy of Breast Pathology from Oakstone CME’s Masters of Pathology Series today and enhance your knowledge and skills in breast pathology. This comprehensive program will provide you with the latest updates and best practices in the field, helping you to deliver accurate diagnoses and improve patient care.
Product Details
- Classify proliferative breast, in situ, papillary, fibroepithelial, spindle cell, and vascular lesions
- Make the distinction between invasive and in situ lesions
- Identify a variety of uncommon benign and malignant lesions
- Understand guidelines for reporting prognostic and predictive factors
- Evaluate diagnostic criteria and clinical significance of various common and uncommon benign, in situ, and malignant lesions of the breast in both core needle biopsy specimens and surgical excision specimens
- Describe differential diagnostic problems commonly encountered in breast pathology and develop strategies to resolve them in the practice environment
- Utilize the latest information on the uses and limitations of immunohistochemistry in resolving diagnostic problems in breast pathology
- Understand the updated guidelines for ER, PR, and HER2 testing and reporting
- Understand the applications of molecular testing in breast cancer